Physician profile
Hajra Awwab
NPI 1073969424
$48,049.05
in general payments reported to CMS, 2019-2025
13 companies · $6,631 in 2025
The $6,631 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.82 · 2021: $38.91 · 2022: $16K · 2023: $19K · 2024: $5,824 · 2025: $6,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Grant: $8,750 · Food and Beverage: $6,568 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,106.30 |
| Grant | $8,750.00 |
| Food and Beverage | $6,567.90 |
| Education | $211.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,185.13 | 2022-2024 | Micra, Tyrx, Plasmablade(Tm) |
| Biotronik INC. | $9,562.64 | 2022-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Selectra |
| Boston Scientific Corporation | $4,275.03 | 2022-2025 | Emblem Mri S-Icd, Watchman Access System, General - Therapies |
| Medical Device Business Services, INC. | $1,300.02 | 2024 | Carto 3 |
| Abbott Laboratories | $372.06 | 2022-2025 | Merlin@Home, Confirm Rx, Aveir |
| Atricure, INC. | $169.53 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Biosense Webster, INC. | $47.35 | 2024 | Carto 3 |
| Cardiva Medical, INC. | $38.27 | 2024 | Ensoetm, Cardiva Vascade Mvp Vvcs 6-12f |
| Akcea Therapeutics, INC. | $31.82 | 2019 | |
| Pfizer INC. | $26.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.09 | 2022 | |
| Merck Sharp & Dohme LLC | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hajra Awwab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.